Tag: Cancer Immunotherapy

Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of ...

A new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor therapies works ...

Enhancer of zeste homolog 2 (EZH2) is a catalytic subunit of the Polycomb-repressive complex 2 (PRC2), which plays a crucial ...

Immunotherapy is one of the pillars in the fight against cancer and aims to enable the body's own immune system ...

Roughly one in five cancer patients benefits from immunotherapy – a treatment that harnesses the immune system to fight cancer. ...

Activated T cells that carry a certain marker protein on their surface are controlled by natural killer (NK) cells, another ...

Cancer is still a leading cause of death worldwide. Globally, there were an estimated 20 million new cases of cancer ...

Findings from St. Jude Children's Research Hospital are moving the field of cancer immunotherapy one step closer to treating brain ...

A "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scientists from UPMC Hillman ...

Liquid biopsies are blood tests that can serially measure circulating tumor DNA (cell-free DNA that is shed into the bloodstream ...